In recent years, mammography and some other cancer screening tests have come under fire from those who claim the medical industry is prone to cancer “overtreatment.” The result, some say, is that U.S. women who find tiny breast cancers then undergo invasive treatments such as chemotherapy for cancers so insignificant that they probably would never have progressed or threatened the patients’ lives.
Although we at EuroMed believe in the importance of cancer screening for the breasts and other areas, we understand the concerns about invasive overtreatment. That’s why we have devoted our practice to alternative cancer therapies that leave a patient strong and healthy while destroying cancerous cells.
A post on The New York Times‘ health blog recently delved into overtreatment and the notion that not all cancers are deadly. Although researchers suspect that some cancers will never harm the patient, there are practically no women out there who want to take the “wait and see” approach, the blog post says.
Surgery, radiation, and chemotherapy, while often effective at eliminating cancer, can also disrupt a patient’s immune system so profoundly that he or she will never be as healthy again. At EuroMed Foundation, we offer treatment options that can help destroy even the tiniest cancers without the unwanted side effects of overtreatment with more invasive options.
Our approach includes low-dose chemo through insulin potentiation therapy and an array of methods to support the immune system by removing toxins from the body and adding essential vitamins and minerals. This gentler approach has helped many patients with breast and other cancers overcome their diseases and go on to live stronger, healthier lives.